Jubilant Pharmova approves ₹800 crore NCD issue through private placement

The Hindu Business Line - Oct 13, 2026

The pharmaceutical company’s board has cleared the debt issue, with the interest rate to be determined through the bidding process.

Read full article
More News
Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.